Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$14.63
-4.00%
Mkt Cap $2.16B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (9 analysts)
$25.00
Range $20.00 – $30.00
Implied Upside
+70.9%
Consensus $25.00 vs current $14.63
NASDAQ·Healthcare·Biotechnology
$14.63
-4.00%
Mkt Cap $2.16B
Buy
10
Hold
0
Sell
0
Price Target (9 analysts)
$25.00
Range $20.00 – $30.00
+70.9%
Consensus $25.00 vs current $14.63